165 related articles for article (PubMed ID: 30662608)
21. Invasive potential of hepatocellular carcinoma is enhanced by loss of selenium-binding protein 1 and subsequent upregulation of CXCR4.
Gao PT; Ding GY; Yang X; Dong RZ; Hu B; Zhu XD; Cai JB; Ji Y; Shi GM; Shen YH; Zhou J; Fan J; Sun HC; Huang C
Am J Cancer Res; 2018; 8(6):1040-1049. PubMed ID: 30034941
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathological and prognostic significance of epithelial mesenchymal transition-related protein expression in intrahepatic cholangiocarcinoma.
Yao X; Wang X; Wang Z; Dai L; Zhang G; Yan Q; Zhou W
Onco Targets Ther; 2012; 5():255-61. PubMed ID: 23091390
[TBL] [Abstract][Full Text] [Related]
23. Elevated expression of G
Cao XY; Ji HJ; Zhou YJ; Lu XF; Shen JY; Wu ZR; Bu H; Shi YJ
Hepatobiliary Pancreat Dis Int; 2017 Dec; 16(6):638-644. PubMed ID: 29291784
[TBL] [Abstract][Full Text] [Related]
24. Adrenomedullin promotes intrahepatic cholangiocellular carcinoma metastasis and invasion by inducing epithelial-mesenchymal transition.
Zhou C; Zheng Y; Li L; Zhai W; Li R; Liang Z; Zhao L
Oncol Rep; 2015 Aug; 34(2):610-6. PubMed ID: 26043778
[TBL] [Abstract][Full Text] [Related]
25. miR-424-5p represses the metastasis and invasion of intrahepatic cholangiocarcinoma by targeting ARK5.
Wu J; Yang B; Zhang Y; Feng X; He B; Xie H; Zhou L; Wu J; Zheng S
Int J Biol Sci; 2019; 15(8):1591-1599. PubMed ID: 31360102
[TBL] [Abstract][Full Text] [Related]
26. Identification of Homer1 as a potential prognostic marker for intrahepatic cholangiocarcinoma.
Wu SY; Yu MX; Li XG; Xu SF; Shen J; Sun Z; Zhou X; Chen XZ; Tu JC
Asian Pac J Cancer Prev; 2014; 15(7):3299-304. PubMed ID: 24815486
[TBL] [Abstract][Full Text] [Related]
27. LncRNA-CCAT1 Promotes Migration, Invasion, and EMT in Intrahepatic Cholangiocarcinoma Through Suppressing miR-152.
Zhang S; Xiao J; Chai Y; Du YY; Liu Z; Huang K; Zhou X; Zhou W
Dig Dis Sci; 2017 Nov; 62(11):3050-3058. PubMed ID: 28921383
[TBL] [Abstract][Full Text] [Related]
28. Mitochondrial pyruvate carrier modulates the epithelial-mesenchymal transition in cholangiocarcinoma.
Ohashi T; Eguchi H; Kawamoto K; Konno M; Asai A; Colvin H; Ueda Y; Takaoka H; Iwagami Y; Yamada D; Asaoka T; Noda T; Wada H; Gotoh K; Kobayashi S; Koseki J; Satoh T; Ogawa K; Doki Y; Mori M; Ishii H
Oncol Rep; 2018 Mar; 39(3):1276-1282. PubMed ID: 29286150
[TBL] [Abstract][Full Text] [Related]
29. Role of the overexpression of TRAF4 in predicting the prognosis of intrahepatic cholangiocarcinoma.
Kang Q; Zou H; Zhou L; Liu LX; Cai JB; Xie N; Li WH; Zhang C; Shi WH; Wang LM; Zhang WH; Zhu H; Wang SF; Zhang XW
Int J Oncol; 2018 Jul; 53(1):286-296. PubMed ID: 29749456
[TBL] [Abstract][Full Text] [Related]
30. CD90 expression in human intrahepatic cholangiocarcinoma is associated with lymph node metastasis and poor prognosis.
Yamaoka R; Ishii T; Kawai T; Yasuchika K; Miyauchi Y; Kojima H; Katayama H; Ogiso S; Fukumitsu K; Uemoto S
J Surg Oncol; 2018 Sep; 118(4):664-674. PubMed ID: 30196535
[TBL] [Abstract][Full Text] [Related]
31. STAT3 overexpression promotes metastasis in intrahepatic cholangiocarcinoma and correlates negatively with surgical outcome.
Yang XW; Li L; Hou GJ; Yan XZ; Xu QG; Chen L; Zhang BH; Shen F
Oncotarget; 2017 Jan; 8(5):7710-7721. PubMed ID: 28032598
[TBL] [Abstract][Full Text] [Related]
32. SATB1 is a potential therapeutic target in intrahepatic cholangiocarcinoma.
Zhao Z; Ma J; Wu K; Chen L; Yu J; Hu W; Zhang K
Clin Transl Oncol; 2016 Sep; 18(9):878-83. PubMed ID: 26563145
[TBL] [Abstract][Full Text] [Related]
33. Knockdown of Sall4 inhibits intrahepatic cholangiocarcinoma cell migration and invasion in ICC-9810 cells.
Zhu L; Huang F; Deng G; Nie W; Huang W; Xu H; Zheng S; Yi Z; Wan T
Onco Targets Ther; 2016; 9():5297-305. PubMed ID: 27601921
[TBL] [Abstract][Full Text] [Related]
34. High Expression of ITGA3 Promotes Proliferation and Cell Cycle Progression and Indicates Poor Prognosis in Intrahepatic Cholangiocarcinoma.
Huang Y; Kong Y; Zhang L; He T; Zhou X; Yan Y; Zhang L; Zhou D; Lu S; Zhou J; Zhou L; Xie H; Zheng S; Wang W
Biomed Res Int; 2018; 2018():2352139. PubMed ID: 29511671
[TBL] [Abstract][Full Text] [Related]
35. NRP1 is a Prognostic Factor and Promotes the Growth and Migration of Cells in Intrahepatic Cholangiocarcinoma.
Wu YN; He LH; Bai ZT; Li X
Cancer Manag Res; 2020; 12():7021-7032. PubMed ID: 32848461
[TBL] [Abstract][Full Text] [Related]
36. EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma.
Hao XY; Cai JP; Liu X; Chen W; Hou X; Chen D; Lai JM; Liang LJ; Yin XY
Chin J Cancer; 2016 Jul; 35(1):70. PubMed ID: 27469137
[TBL] [Abstract][Full Text] [Related]
37. Fatty acid-binding protein 5 promotes cell proliferation and invasion in human intrahepatic cholangiocarcinoma.
Jeong CY; Hah YS; Cho BI; Lee SM; Joo YT; Jung EJ; Jeong SH; Lee YJ; Choi SK; Ha WS; Park ST; Hong SC
Oncol Rep; 2012 Oct; 28(4):1283-92. PubMed ID: 22825302
[TBL] [Abstract][Full Text] [Related]
38. Aberrant expression of GATA binding protein 6 correlates with poor prognosis and promotes metastasis in cholangiocarcinoma.
Tian F; Li D; Chen J; Liu W; Cai L; Li J; Jiang P; Liu Z; Zhao X; Guo F; Li X; Wang S
Eur J Cancer; 2013 May; 49(7):1771-80. PubMed ID: 23313142
[TBL] [Abstract][Full Text] [Related]
39. Upregulation of
Wu L; Ling ZH; Wang H; Wang XY; Gui J
Cancer Biother Radiopharm; 2019 Dec; 34(10):642-649. PubMed ID: 31549859
[No Abstract] [Full Text] [Related]
40. SALL4 is a novel therapeutic target in intrahepatic cholangiocarcinoma.
Deng G; Zhu L; Huang F; Nie W; Huang W; Xu H; Zheng S; Yi Z; Wan T
Oncotarget; 2015 Sep; 6(29):27416-26. PubMed ID: 26317546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
